Miljkovic Milos
SEC insider (Form 3/4/5 filer). CIK 0002000282. Chief Medical Officer at Cartesian Therapeutics, Inc. (RNAC). 9 reported Form 4/5 transactions since Sep 2024; latest on Jan 6, 2026. Located in FREDERICK, MD.
Companies Miljkovic Milos has filed insider reports for
- Cartesian Therapeutics, Inc. (RNAC): Officer, Chief Medical Officer
Miljkovic Milos
CIK: 0002000282
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
Cartesian Therapeutics, Inc.
Discretionary Trading P&L
Holdings
Transaction History (9 total)
- Jan 6, 2026RNAC
Cartesian Therapeutics, Inc.
SaleDirect3.6K shares at avg. $6.82$24K - Jan 2, 2026RNAC
Cartesian Therapeutics, Inc.
AwardDirect27K shares- - Jan 6, 2025RNAC
Cartesian Therapeutics, Inc.
SaleDirect948 shares at avg. $16.83$16K - Jan 3, 2025RNAC
Cartesian Therapeutics, Inc.
SaleDirect932 shares at avg. $16.72$16K - Jan 2, 2025RNAC
Cartesian Therapeutics, Inc.
AwardDirect19K shares- - Nov 15, 2024RNAC
Cartesian Therapeutics, Inc.
SaleDirect20K shares at avg. $17.14$343K - Nov 15, 2024RNAC
Cartesian Therapeutics, Inc.
ExerciseDirect20K shares at avg. $3.23$65K - Nov 14, 2024RNAC
Cartesian Therapeutics, Inc.
SaleDirect35K shares at avg. $16.13$565K - Nov 14, 2024RNAC
Cartesian Therapeutics, Inc.
ExerciseDirect35K shares at avg. $3.23$113K
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Jan 6, 2026 | RNAC Cartesian Therapeutics, Inc. | Sale | 3,573 | $6.82 | $24,367 | Direct |
| Jan 2, 2026 | RNAC Cartesian Therapeutics, Inc. | Award | 27,000 | - | $0 | Direct |
| Jan 6, 2025 | RNAC Cartesian Therapeutics, Inc. | Sale | 948 | $16.83 | $15,957 | Direct |
| Jan 3, 2025 | RNAC Cartesian Therapeutics, Inc. | Sale | 932 | $16.72 | $15,585 | Direct |
| Jan 2, 2025 | RNAC Cartesian Therapeutics, Inc. | Award | 19,000 | - | $0 | Direct |
| Nov 15, 2024 | RNAC Cartesian Therapeutics, Inc. | Sale | 20,000 | $17.14 | $342,888 | Direct |
| Nov 15, 2024 | RNAC Cartesian Therapeutics, Inc. | Exercise | 20,000 | $3.23 | $64,600 | Direct |
| Nov 14, 2024 | RNAC Cartesian Therapeutics, Inc. | Sale | 35,000 | $16.13 | $564,645 | Direct |
| Nov 14, 2024 | RNAC Cartesian Therapeutics, Inc. | Exercise | 35,000 | $3.23 | $113,050 | Direct |
1-9 of 9 transactions